Myomo, Inc. (MYO)
| Market Cap | 98.00M |
| Revenue (ttm) | 19.24M |
| Net Income (ttm) | -8.15M |
| Shares Out | 28.49M |
| EPS (ttm) | -0.28 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 70,756 |
| Open | 3.540 |
| Previous Close | 3.540 |
| Day's Range | 3.430 - 3.630 |
| 52-Week Range | 0.371 - 5.580 |
| Beta | 1.53 |
| Analysts | Strong Buy |
| Price Target | 4.25 (+23.55%) |
| Earnings Date | May 8, 2024 |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of... [Read more]
Financial Performance
In 2023, Myomo's revenue was $19.24 million, an increase of 23.70% compared to the previous year's $15.56 million. Losses were -$8.15 million, -24.00% less than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for MYO stock is "Strong Buy." The 12-month stock price forecast is $4.25, which is an increase of 23.55% from the latest price.
News
Myomo Appoints Heather Getz to its Board of Directors
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Report Third Quarter Financial Results on November 7, 2023
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Announces Closing of $4.4 Million Public Offering
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Announces Pricing of $4.4 Million Public Offering
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo, Inc. Announces Proposed Public Offering
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Report Second Quarter Financial Results on August 9, 2023
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Centers for Medicare and Medicaid Services Accepts Myomo's Application to Classify the MyoPro® as a Brace
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Report First Quarter Financial Results on May 10, 2023
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Receives Technology License Fee Payment from China Joint Venture Company
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Makes NYSE American Section 610(b) Public Announcement
BOSTON--(BUSINESS WIRE)--Myomo, Inc.
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...